JAMA Neurology : Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease

Interview with Charbel Moussa, MD, PhD, author of Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial
Source: JAMA Specialty Journals Author Interviews - Category: General Medicine Source Type: podcasts